RN7SL346P

Across TCGA pan-cancer cohorts, RN7SL346P RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated RN7SL346P data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher RN7SL346P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL346P expression acts as an unfavorable survival marker, although some lineages such as COAD and HNSC show a favorable association.

UCS, SKCM, and LIHC are the cancer types where RN7SL346P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	OS	Tertile	All	0.148	0.709	<.001	108	view →
SKCM	DFS	Tertile	All	0.256	0.742	<.001	96	view →
LIHC	OS	Tertile	II,III,IV	0.197	0.726	<.001	81	view →
THCA	OS	Tertile	All	0.624	0.934	<.001	72	view →
ACC	DFS	Tertile	All	0.110	0.673	.001	60	view →
GBM	OS	Tertile	All	0.160	0.428	<.001	45	view →
TGCT	OS	Tertile	All	0.069	0.968	<.001	36	view →
ESCA	DFS	Quartile	II,III,IV	0.375	0.625	.001	36	view →
LUAD	DFS	Tertile	IV	0.472	0.771	.024	30	view →
COAD	DFS	Tertile	All	0.842	0.671	.024	24	view →
KIRC	OS	Tertile	All	0.714	0.889	.019	12	view →
HNSC	DFS	Tertile	IV	0.666	0.222	.037	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

RN7SL346P–UCS (OS)

Open the UCS breakdown →